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Summary Although the need for a method of measuring the quality of life of patients undergoing therapy
for cancer has been widely recognised, no adequately evaluated or feasible method has been established. We
describe a method in which 31 items were assessed by patient self report using linear analogue scales.
Eighteen items inquiring about general health problems were derived from the Sickness Impact Profile, an
established method of assessing the effect of health upon behaviour and function. Thirteen items inquiring
about major problems associated with breast cancer were derived from clinical experience and the opinions of
patients with this disease.
Each item of the measurement method (instrument) has been evaluated for content, feasability, reliability
and validity by methods that are widely used in psychometry but less familiar in medicine. It appeared easy to
use, acceptable and reliable in these assessment. Validity was evaluated indirectly since no standard
measurements of quality of life exist for comparison. Most items appeared valid when compared to
alternative measurement methods including the Sickness Impact Profile and evaluation by a physician in a
structured interview. The correlations between items in the instrument were analysed by factor analysis and
seemed to fit with the clinical features of breast cancer. The method distinguished between clinically distinct
groups ofpatients and detected changes with time.
The study illustrates the possible approaches to the scientific evaluation of methods for measuring
subjective features of patients lives. This method appears suitable for some purposes to measure quality of life
in breast cancer and is intended to be flexible enough to be modified for other diseases. However, further
evaluation, development and refinement will be needed before routine clinical application can be
recommended.
When assessing the benefits of a treatment for a
potentially disabling or fatal illness, we need to
know about survival and the quality of survival. In
cancer therapy, tumour volume changes, measures
of treatment toxicity, patient performance status or
disease-free interval may give valuable information.
However, measurement of the quality of life of
surviving patients is not at present possible because
there is no adequately evaluated and feasible
method for this purpose. The need for such a
method is widely recognised. Its successful
applications might include the identification of
damaging effects of disease or treatment which
could be reduced by changes in therapy. It may be
possible to compare the effects of alternative
treatments on both the quality and duration of
survival. The provision of a more complete
description of the effects of treatments might allow
patients and physicians to choose more easily
between alternatives.
Several problems must be addressed before
measurement of the quality of life of patients can be
used for these purposes. The first group of problems
concerns the design of a method of measurement,
and the second, the evaluation of the method before
it is used in the clinical setting. In designing a
method, decisions must be made about its scope,
detail, whether data will be obtained from patients
self-report or from others such as interviewers or
physicians, and whether qualitative descriptions or
quantitative measurements should be sought. The
selection of an appropriate scope of inquiry is
particularly important. Restriction of measurements
to symptoms alone may fail to assess the impact of
the disease on the patients whole life. On the other
hand inquiries which attempt to be comprehensive
(global) may fail to assess adequately a dominant
symptom or preoccupation and tend to be lengthy
and time-consuming. When the design problems are
resolved, the method must be evaluated to find out
if it meets the standards of other measurements
used in medicine. Is it easy to use in a clinical
setting and how large are the errors associated with
the measurement (i.e. how reliable* is it)? Does it
measure what it is intended to measure (i.e. how
valid* is it)?
In this paper we describe an attempt to address
these issues in the development of a method of
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measurement (a measurement "instrument"*) for the
perceived quality of life of cancer patients. Data
were collected by patients self assessment using
linear analogue scales which are quite widely used
in psychology but only recently applied in clinical
oncology (Aitken, 1969; Bond & Lader, 1974;
Priestman & Baum, 1976).
Two groups of items were chosen to define the
scope of the method. Firstly, a global group were
drawn from an existing comprehensive health index,
the Sickness Impact Profile (SIP) (Bergner et al.,
1981). The second group of items were selected to
assess important areas related to the disease under
study. We chose to study breast cancer because of
its frequency and because we believe that
measurement of quality of life may be particularly
important when the outcome of treatment is often
palliation and treatments may be unpleasant.
Methods and results
Patient population
All patients attending a clinic for the medical
management of breast cancer at the Princess
Margaret Hospital between March 1981 and
February 1982 were asked to take part in this study
if they were able to understand spoken and written
English. We attempted to include all eligible
patients seen during the period of the study.
Patients were asked to take part in these studies on
275 occasions and did so on 246 occasions. Patients
refused on 29 occasions, often for reasons unrelated
to the study, such as language difficulties (5
patients), recent bereavement (2 patients), and lost
spectacles (1 patient). However, a few patients were
unwilling to take part in studies of this type,
including two who said that the questions made
them more aware of their disability, three who said
that too much time was required, and two others
who wished to discuss their health only with their
own physician.
Five groups of patients, each of which were
accrued separately, were studied.
I 31 patients with either recurrent disease (16) or
receiving adjuvant therapy (15). Mean age 51
years.
II 96 patients with recurrent disease aged<70
years. 52 receiving chemotherapy. Mean age 57
years.
*The word "instrument" is widely used in psychology
and psychiatry to denote a structured questionnaire which
is subjected to formal assessment. Reliability is defined as
the amount of random error in a measurement-error
variance. Validity means the extent to which a
measurement appropriately measures that which it is
intended to measure.
III 50 patients with recurrent disease. 27 receiving
chemotherapy. Mean age 58 years.
IV 31 patients with recurrent disease. 13 receiving
chemotherapy. Mean age 55 years.
V 23 patients receiving adjuvant chemotherapy for
lymph node positive breast cancer surgically
resected. Mean age 48 years.
Design ofthe selfassessment method
Selection of items The Sickness Impact Profile
contains 136 questions grouped into 12 categories.
It is based upon descriptions provided by a large
and heterogeneous group of people about the way
their behaviour and functions had been affected by
illness. Each of the 12 categories can be scored
separately to provide a quantitative index of
severity, and in addition, a weighted overall score,
which summarize the scores of all categories, can be
generated (Bergner et al., 1981). Five of the 12
categories in SIP (Work, Home Management,
Recreation and Pastimes: Mobility, and Alertness
Behaviour) were each represented by one linear
analogue scale in our self assessment instrument.
Two categories (Eating, Sleep and Rest) were each
represented by 2 linear analogue scales to allow
scoring of an increase or decrease in the activity.
Five categories in SIP were represented by more
than one linear analogue scale. The category, Social
Interaction, in SIP was represented by separate
scales for Social Life and Family Relationships, the
SIP category of Body Care and Movement was
represented by separate scales for Self-care and
Physical Activity. The SIP category for Ambulation
was represented also by this scale for Physical
Activity. The SIP category of Emotional Behaviour
was represented by separate scales for Anxiety,
Depression, and Anger. The SIP category for
Communication was represented by scales for
Speech and for Writing.
The 12 categories of SIP thus gave rise to a total
of 18 linear analogue scales that enquired about
different aspects of general health.
In addition, we selected 12 items on the basis of
clinical experience that described clinical problems
or side effects of treatment that are common in this
patient population. These were Pain, Breathing,
Sore Mouth, Nausea, Vomiting, Hair Loss,
Attractiveness, Appearance, Dysuria, Constipation,
Diarrhoea and Fatigue. Each of these items was
represented by one linear analogue scale.
Finally, we included an item related to overall
quality of life referred to as the Uniscale (Figure 1)
giving a total of 31 scales.
Design of items Each item was represented in the
self assessment instrument by a title and a 10cm
linear analogue scale. Each scale was anchored at
its ends by descriptive phrases, the right hand endQUALITY OF LIFE IN CANCER PATIENTS 15
Figure 1
The overall score (this scale) completed by patients and physicians.
PLEASE SCORE HOW YOU FEEL YOUR LIFE HAS BEEN AFFECTED BY
THE STATE OF YOUR HEALTH (ANY DISEASE OR TREATMENT)
DURING TODAY (24h).
You may like to look back over the previous scales and consider the scores you have made and
how much you feel they have affected your life.
My life is
extremely unpleasant
because of the
state of my health
My life is normal
for me with no
changes because of
the state of my
health
Figure 2
Linear analogue self assessment scales - three examples completed by patients and physicians
PLEASE SCORE HOW YOU FEEL EACH OF THESE ASPECTS OF YOUR
LIFE WAS AFFECTED BY THE STATE OF YOUR HEALTH DURING TODAY (24h)
2. Nausea
extremely severe no nausea
nausea
13. Physical Activity
completely unable
to move my body
normal physical
activity for me
20. Depression
extremely
depressed
not depressed
at all
of the line describing normality or the absence of a
symptom and the left hand end the opposite
extreme of the state. Examples are shown in Figure
1. Items were randomly ordered to reduce the
chance of scores on one item influencing scores on
related adjacent items.
The patients were asked to place a vertical mark
on each linear analogue scale in a position that
they felt best described their own state with regard
to that item. They were asked to consider the
previous 24h in some studies and previous 7 days
in others (Table I). These instructions and the
methods to be used were explained to patients in a
standard way by one of two research assistants who
answered any questions from patients before the
first completion of the self assessment instrument.
To score patients' responses, each linear analogue
scale was assigned a value 10 at the end indicating
normality or the absence of a symptom, and 0 at
the other end. The line was then measured in
millimeters from 0. Higher scores thus indicated
better health or less severe symptoms.
Verification of content (regression analysis) We
assessed the relevance and importance of the
selected items to patients with breast cancer by
inviting comments from 31 patients (Group I) in an
open questionnaire and by direct questioning a
further 30 patients. These enquiries indicated that
the items included were relevant and important to
patients with this disease and elicited the suggestion
that one item be added asking about satisfaction16 P.J. SELBY et al.
Table I Summary of studies
Property Duration of
evaluated Method ofevaluation Patient group (No.) enquiry (days) Analytic method
Feasibility Time to complete I (31) 1
Acceptance rate All (275) 1 or 7
Item selection Patients opinion I (31) 1
Regression analysis II (96) 7 Multiple regression
Reliability Test-retest comparison II (96) 7 Correlation
I (31) 1 Correlation
Split halfreliability II (96) 7 Cronbach's alpha
Validity Relationship between
scores for different items II (96) 7 Factor analysis
Comparison to Sickness
Impact Profile scores III (50) 1 Correlation
Comparison to Karnofsky
Index scores III (50) 1 Correlation
Comparison to physician
scores III (50) 1 Correlation
Distinguish between groups II,V (75) 7 Comparison of means
(t test)
Distinguish change over Comparison of means
time II,V (65) 7 (paired t test)
with information-provided about the disease and its
treatment. This was done to give a final total of 32
scales (including the Uniscale).
In order to investigate further how completely the
instrument might describe the quality of life of our
patients, we examined the relationship between the
31 items each describing an aspect of their lives and
the Uniscale which set out to provide a single
overall score for quality of life. We made the
hypothesis that the extent to which the variation in
the Uniscale score was explained by the variation in
the 31 items might be used as an indication of the
completeness of item selection. We used the 96
patients' scores from Group II who completed the
instrument on three occasions (twice for test-retest
comparison and once a week later), and we
determined the extent to which variation in
Uniscale scores could be explained by variation in
the scores of individual items using a multiple
regression analysis. The patients' self-assessed
quality of life score on the Uniscale was treated as
the dependent variable in this analysis, and the
scores of the remaining 31 items were treated as
independent variables.
Variation in the scores for items was able to
explain between 68% and 83% of the variation in
Uniscale. Most of the variation in Uniscale scores,
in each of the three analyses, was explained by
variation in scores of Physical Activity, although
scores for Depression also made a significant
contribution. Other variables including Social Life,
Anxiety and Appearance made significant
contributions to one or more of the three analyses,
but not to all of them.
This result suggests that the items selected do
make a major contribution to the patients'
perceived quality of life. However, this result should
be interpreted with caution because Uniscale was
completed by patients immediately after completing
the other scales and the independence of the two
measures is thus not assured.
Statistical procedures
Scores for all items had a unimodal distribution
that was highly skewed toward the end of the scale
indicating normality or the absence of a symptom.
The influence of this distribution upon the
statistical analyses was examined in two ways. First,
we performed all analyses before and after the
exclusion of scores that indicated normality. This
was done by arbitrarily selecting a cut-off point at
9.5, and excluding all scores above this point.
Second, all analyses were carried before and after
transformation of the data to obtain a more normal
distribution. Several methods of transformation
were examined for this purpose including log
transformation, arc-sin transformation, and arc-
cosine transformations. Arc-cosine transformation
resulted in the most normal distribution of values
and was the procedure adopted by us.
The statistical tests employed are listed in Table
I. Coefficients of agreement (intra-class correlation
coefficients), Pearson product-moment correlationQUALITY OF LIFE IN CANCER PATIENTS 17
coefficients, and t-tests were carried out using the
Statistical Packages for the Social Sciences (SPSS),
Update 7-9. Factor analysis was done using the
Exploratory Factor Analysis Program (Goreskog &
Solbom, 1978). The Multiple Regression Analysis
was performed using SPSS computer programmes.
No generally accepted rules exist for the degree of
correlation which is required to support or refute
the reliability or validity of a test. In this study we
have followed the general recommendations of
Nunnally (1978) for a test used in a research setting.
These probably represent quite rigorous criteria for
the assessment of individual items within the
instrument. Summation of item scores would lead
to higher reliability or validity estimations.
Coefficients of correlation are regarded as strongly
supporting reliability when greater than 0.7.
Validity estimations are constrained at their upper
limit by the reliability of the item and coefficients
greater than 0.6 strongly argue for validity.
Reliability coefficients are expected not to be lower
than validity measurements on theoretical grounds.
For readers who prefer to evaluate the correlation
coefficients by estimating their statistical
significance, we have given P values in footnotes to
the Tables. In all cases, correlation coefficients of
more than 0.6 were significant at the P<0.01 level.
Evaluation ofthe self assessment method
We evaluated the feasibility of the instrument in the
clinical setting as well as the reliability and validity
of the resulting scores using methods that are
summarized in Table I. The results are described for
each objective rather than for each separate study.
Feasibility The 31 patients in Group I each
completed the instrument on 4 occasions. Mean
completion time was 3.6min (±2.6min, s.d).
Reliability The reliability of each scale was
assessed by asking the 96 patients in Group II to
complete the instrument on 2 occasions. The first of
these was in the morning in the Outpatient Clinic,
and the second 9-12h later at home. Test-retest
reliability was assessed by comparing the scores
recorded on these two occasions. We anticipated
that the patient's clinical state would not change
between the first and second completions of the
instrument, but some patients in this group did
receive chemotherapy between test and retest. Table
II shows the coefficients of agreement between the
scores completed on two occasions. Sixteen of the
18 scales for general health items gave correlations
of agreement greater than 0.70 and the remaining
two were between 0.60 and 0.70. Seven of the 13
scales for disease or treatment related items were
also above 0.70 and three were between 0.60 and
0.70. The coefficient of agreement for Uniscale, the
global quality of life scale, was 0.72.
The scales for nausea, vomiting and diarrhoea
appear less reliable in this setting, with coefficients
of agreement less than 0.40. To examine the
possibility that the reliability of scores for these
symptoms had been influenced by the
administration of chemotherapy between the first
and second completions of the instrument, we
recalculated coefficients of agreement after excluding
patients who received chemotherapy. Higher
coefficients of agreement were observed (0.40 for
nausea and 0.30 for Vomiting) but they remained
lower than for the other items. The suggestion that
these low scores may be explained by the
intervening chemotherapy is supported by the
Table II Test-retest reliability of items
General Health item Disease related item
Item r Item r Item r Item r
Work 1.00 Social life 0.78 Dysuria 0.85 Sore mouth 0.68
Increased Housework 0.75 Attractiveness 0.84 Breathing 0.66
eating 0.96 Reduced Pain 0.83 Fatigue 0.66
Writing 0.92 eating 0.74 Information 0.79
Anger 0.90 Physical Constipation 0.79 Diarrhoea 0.37
Reduced activity 0.72 Hair loss 0.78 Nausea 0.32
sleep 0.82 Family Appearance 0.78 Vomiting 0.25
Concentration 0.81 relations 0.70
Self care 0.81 Anxiety 0.70
Depression 0.80 Uniscale 0.72
Increased
sleep 0.79 Mobility 0.64
Speech 0.63
Recreation 0.78
Correlationcoefficients arehighlysignificant,P<0.001,exceptthoseforDiarrhoea(P=0.005),Nausea(P=0.002)
and Vomiting (P=0.012).18 P.J. SELBY et al.
findings of a small test-retest reliability study of the
31 patients in Group I who completed the
instrument in the evening before clinic and again on
arrival in the clinic. These results are not shown in
full. However, the test-retest correlation coefficient
for the scale for Nausea and Vomiting in this study
was greater than 0.7.
The reliability of the whole instrument was
further examined by comparing scores in 2 halves
for the 96 patients in Group II ("split-half
reliability") using methods described by Cronbach
(1951). Cronbach's statistic Alpha gave a value of
0.91. This statistic is widely used for evaluating
measurement instruments and this value supports
the general impression of reliability here. However
there are theoretical objections to its use for this
purpose (Cronbach, 1951) and it must be
interpreted cautiously.
To examine the influence of scores that indicated
no impairment for an item upon the assessment of
reliability, all of the data shown were analysed
before and after the exclusion of scores above 9.5.
Further analyses were carried out after arc-cosine
transformation of scores to assess the effect upon
the results of data that were not normally
distributed. In both instances, co-efficients of
agreement were obtained that were very similar to
those shown in Table II and the general conclusions
presented in that Table were not altered by these
additional analyses.
Validity Validity, the extent to which scores truly
describe the severity of the state being assessed, is
the most difficult aspect of evaluation because there
is no accepted alternative method of measurement
to serve as a criterion against which the present
instrument can be judged. In the absence of such a
criterion, we adopted four indirect methods for
evaluating validity.
1. Correlations between scores for items within the
Instrument (Factor Analysis).
The extent to which scores on individual items
correlated with scores on other related items was
assessed. Thus, it is expected that patients with
severe pain or extreme difficulty in breathing will
also be restricted in physical activity and, if the item
is a true measure of the patients' state, that the
scores on these items will be correlated with each
other. The relationship between the item scores by
the 96 patients in Group II was assessed using
factor analysis (Gorsuch, 1974). This computer-
based technique examines correlations between
scores on all items and creates groups of items
whose scores are most strongly correlated with each
other. If scores are valid it is expected that the
groups created by factor analysis will be comprised
of items that are expected, on clinical or other
grounds, to be associated with each other.
The results are shown in Table III. The item
"Work" was omitted from this analysis because of
the large number of patients who did not normally
work outside the home. The items for Mouth
Soreness, Dysuria, Speech and Self Care had a very
narrow distribution in the upper part of the range
(means >9.5) and their variance was too small to
allow factor analysis. The item for Sleep did not
correlate significantly with any factor.
Table III shows the five groups of items, or
"factors", that were generated by this analysis.
Each factor is comprised of items whose scores
were strongly correlated with that factor. The
factor "loadings", which are shown in the Table in
parenthesis, are a measure of the strength of this
association, and can be considered similar to a
correlation coefficient. The items of Physical
Activity, Concentration, and Family Relations were
each significantly associated with two factors.
Factor analysis yields groups of items which can
Table III Correlations between items: factor analysis
Factor I Factor 2 Factor 3 Factor 4 Factor 5
Housework (0.89) Pain (0.60) Depression (0.80) Nausea (0.86) Attractiveness (0.64)
Recreation (0.85) Physical activity (0.57) Anger (0.77) Vomiting (0.85) Family relations (0.63)
Social life (0.71) Bowel habit (0.54) Anxiety (0.68) Eating (0.38) Hair loss (0.35)
Mobility (0.49) Breathing (0.42) Appearance (0.40)
Fatigue (0.46) Concentration (0.40)
Writing (0.44) Family
Physical relations (0.38)
activity (0.42)
Concentration (0.40)
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be said to be associated on statistical grounds. The
analysis will only support the validity of the
instrument if the factorial associations appear on
independent grounds to be biologically or clinically
real. It is the authors' opinion, based on their
experience of the clinical features of metastatic
breast cancer, that the factors in general show the
relationships expected in this disease. Factors 1 and
2 reveal the relationship between impaired physical,
recreational, social and working activities and the
common symptoms - fatigue, pain and
breathlessness - that are responsible for functional
impairment in breast cancer. The association of
pain with altered bowel habit may well be explained
by the constipating effect of analgesics. Factor 3
expressed expected associations between different
emotional disturbances and their effect on
concentration and family relations. The impact of
physical appearance on emotional state in this
disease is widely recognised. Factor 4 represents
alimentary disturbance by disease and treatment.
Factor 5 shows the effect of hair loss on the
perception on attractiveness whichmight be expected
to influence relationships with other family
members, particularly spouses.
The factor analysis does appear to show that
clinically related items are associated with each
other and hence supports the validity of the
measurement method.
2. Comparison with scores obtained by alternative
methods (the Sickness Impact Profile, Physician
Interviews and Karnofsky scores).
The group of items intended to measure general
health features, derived from the Sickness Impact
Profile, was evaluated by comparison of linear
analogue scores to category scores in SIP in the 50
patients in Group III. All of the scores for self
assessment on the linear analogue scales by this
group of patients were compared to scores made by
a physician on a linear analogue scale. The
physician was not involved in the patients care and
his interview was carried out in a structured way.
The first part consisted of an open interview in
which the patients were encouraged to describe
their symptoms and related problems. The second
part consisted of specific questioning about each
item of the questionnaire. The Uniscale scores were
compared to a Uniscale score given by the
physician, to the weighted sum given by the
Sickness Impact Profile and to scores on the
Karnofsky Performance Index (Karnofsky &
Burchenal, 1949).
(i) The Sickness Impact Profile
Table IV shows the correlation coefficients
observed when scores obtained from the 18 items
related to general health were compared with the
scores derived from the associated categories of the
Sickness Impact Profile.
Table IV Correlation of item scores with Sickness
Impact Profile categories
Direct comparisons Indirect comparisons
Item r Item r
Work 0.97 Depression 0.98
Housework 0.71 Self care 0.74
Overall Social life 0.71
score 0.70 Writing 0.62
Physical Speech 0.48
activity 0.65 Anxiety 0.48
Reduced
eating 0.64 Family
Mobility 0.62 relations 0.41
Recreation 0.47
Sleep 0.38
Concentration 0.47 Anger 0.28
Coefficients significant (P<0.001) except those for
Family relations (P<0.005), Sleep and Anger (P<0.05).
Because of the way in which items were selected
(see Selection of items) some did not directly
correspond to a category in the Sickness Impact
Profile. For example, the Sickness Impact Profile
does not generate separate scores for Anxiety and
Depression although questions concerning each of
these symptom complexes are contained in the
Sickness Impact Profile category, "Emotional
Behaviour". We therefore compared the item scores
for Anxiety and Depression for the self assessment
instrument with the Sickness Impact Profile
category of Emotional Behaviour. Indirect
relationships of this type are listed separately in
Table IV.
All correlation coefficients between items in the
self assessment instrument and the Sickness Impact
Profile were statistically significant (P<0.001). As
expected, correlations were strongest when there
was a direct correspondence between an item and a
Sickness Impact Profile category, where 7 of 8
comparisons gave correlation coefficients greater
than 0.60. For the 9 items where there was only an
indirect relationship between the compared scores,
4 correlation coefficients were greater than 0.60, 3
between 0.40 and 0.50 and 2 were less than 0.40.
These correlations were again carried out before
and after the exclusion of scores greater than 9.5,
and after arc-cosine transformation of scores, with
results that remained very similar to those shown in
Table IV.
(ii) Physician Interviews
Before comparing the linear analogue scores of
patients and a physician, we first assessed the
reliability of linear analogue scoring by a physician
by comparing the scores assigned by two of us (PS
and NFB) who independently interviewed a series
of 30 patients with metastatic breast cancer (Group20 P.J. SELBY et al.
IV). The comparison of these scores showed that
the coefficients of agreement on scores between two
physicians were similar to test-retest reliability
when patients completed the instrument.
Table V shows the correlation coefficients
obtained when the scores assigned by patients were
compared with those assigned by the physician.
Eleven of the 18 general health items have
correlation coefficients greater than 0.70 and a
further 3 were between 0.60 and 0.70. Six of the 12
disease or treatment related items had correlation
coefficients greater than 0.70, and 3 were between
0.60 and 0.70.
Correlation coefficients were less than 0.5 for six
items: Increased Sleep, Speech and Anger from the
general health group; Sore Mouth, Information and
Dysuria from the disease-related group. Closer
inspection of the data shows that both patients and
physician scores were high (mean value >9.5) with
small variance for the items Speech, Sore Mouth
and Dysuria so that substantial agreement existed
which is not reflected in the correlation coefficient
because of lack of dispersal of the data. However,
scores were adequately dispersed for the items
Anger, Information and Increased Sleeping and the
low correlation coefficients indicate poor
agreement.
Although the scores of patients and the physician
were, for the most part, strongly correlated, the
variances associated with these scores differed
systematically. The variance of the linear analogue
scores assigned by a physician were often 1/2 and
sometimes 1/5 that of the scores for the patients
themselves. This finding is not unexpected, because
the variances in the patients' scores arise both from
differences between individuals (i.e. from differences
in the severity of symptoms between individuals)
and from differences in the error associated with
measurement and the latter source of variation
would be expected to a substantially reduced in the
measurements made by a single trained individual.
(iii) Overall scores
The Uniscale scores completed by the patient and
by the physician together with the physician scores
for the Karnofsky Index and the overall weighted
sum deduced from the Sickness Impact Profile
might be regarded as single figures intended to give
an overall indication of the patients' well being.
Coefficients of agreement between these were
examined and they were all highly significantly
(P<0.001) intercorrelated. The patients Uniscale
score correlated closely with the physicians Uniscale
score and the SIP overall score (r>0.7) and
moderately with the Karnofsky Indexes (r>0.6).
3. Distinction between groups of patients
The scores of patients with metastatic breast cancer
in Group II were significantly lower, indicating
greater impairment, than those of patients receiving
adjuvant chemotherapy in Group V for the items of
Mobility, Breathing, Pain, Physical Activity,
Housework, Writing and Reduced Eating. Patients
receiving adjuvant therapy scored significantly
lower for the items of Hair Loss, Attractiveness, and
Increased Eating. Scores for Hair Loss and
Attractiveness remained significantly lower in the
adjuvant group even when the comparison was
confined to patients with metastatic disease who are
receiving identical chemotherapy. The instrument
was therefore able to distinguish clinically different
groups of patients.
4. Detection of change with time
Patients with metastatic breast cancer in Group II
and patients receiving adjuvant chemotherapy, were
Table V Correlation of scores from self assessment and assessment by a physician
General health item Disease related item
Item r Item r Item r Item r
Writing 0.88 Family relations 0.70 Diarrhoea 0.98 Nausea 0.62
Mobility 0.78 Housework 0.69 Constipation 0.89 Appearance 0.57
Self care 0.77 Concentration 0.66 Hair loss 0.80 Sore mouth 0.40
Physical activity 0.76 Anxiety 0.60 Breathing 0.80 Information -0.09
Recreation 0.76 Depression 0.58 Fatigue 0.74 Dysuria -0.04
Social life 0.75 Increased sleep 0.37 Pain 0.72
Reduced eating 0.75 Speech 0.29 Attractiveness 0.66
Reduced sleep 0.75 Anger 0.11 Vomiting 0.64
Work 0.75
Increased eating 0.71
Coefficients significant (P<0.001) except those for Increased Sleep, Sore Mouth and Speech (P<0.05), Anger,
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asked to complete the instrument one week after
their attendance at clinic. We anticipated here that
the instrument should register the changes predicted
due to the acute side effects of chemotherapy during
that week. Among 42 patients in Group II who
received cytotoxic drugs on the day of their
attendance in clinic, there was a significant
reduction in scores for nausea (P<0.001), vomiting
(P<0.05) and sore mouth (P<0.02) in the scores
completed one week later. Similar changes occurred
in the group of patients receiving adjuvant
chemotherapy, although only the change of nausea
achieved conventional levels of statistical
significance (P<0.01).
Discussion
Our purpose in this study was to design and
evaluate a method of collecting information about
the quality of life of patients with breast cancer. The
items selected for inclusion were intended to cover
most important aspects of general health as well as
to focus on important particular problems in breast
cancer. The separation of the groups of items was
intended to allow flexability in redesigning the
method for other clinical applications.
Our assessment of the design of the measurement
method was encouraging. Patients found it to be
quick, easy and acceptable. They reported that it
covered most important areas of their lives and the
Regression Analysis appeared to support that
conclusion. The results appear to be acceptably
reliable in each item for an instrument used in a
research setting. The low reliability of scales for
Nausea and Vomiting appear to be due to the
experimental design in that intervening
chemotherapy influenced retest scores.
There is strong support from the several studies
for the validity of the measurement method in most
items. However, in the absence of some established
method of assessment to serve as a criterion of
"gold standard", all approaches to validation are
necessarily indirect. Several items performed poorly
in the validation studies. There was poor agreement
between the patient item scores for Anger and for
Sleeping and scores given by the physician or those
obtained from the related category of the Sickness
Impact Profile. The item for Sleeping showed no
significant associations in factor analysis although
Anger was, probably appropriately, associated with
other emotional disturbances. The patients' item
scores for assessment of Information were not
correlated with the physicians opinion of this
situation. Some aspects of validity, such as the
ability of the method to distinguish different groups
or clinical changes, although supported by our
results, require further studies in larger patient
numbers.
Although agreement between the scores of
patients and their physician was generally
satisfactory, the substantially greater variance of the
patient scores has implications for the design of
studies using scales of this type as endpoints. The
sample size required to detect a difference of a given
size will be substantially reduced if scores are
recorded by a physician (or other suitably trained
individual) rather than by a group of patients.
However, for some items, notably Anger and
Information, patients appeared unwilling to share
their thoughts with their physician.
We have avoided adding scores into summary
numbers in this study and we have concentrated on
the evaluation of reliability and validity for
individual items because it is more rigorous than
evaluating summary scores. No assumptions about
the relationship of the items to a common unifying
theme are necesary. It seems likely that the need
for summary scores will be determined largely by
the purposes for which the instrument is used, and
for some purposes the separate item scores will be
sufficient. Summary scores of groups of items, such
as those groups suggested by the Factor Analysis,
may be required for other applications. If such
aggregation is attempted, attention must be paid to
the importance (or weight) attached to each item,
rather than simply adding scores from several items,
and we have not yet addressed the issue of
weighting. Although some authors have derived
measurement methods which yield single number
estimates of "quality of life" (Spitzer et al., 1981), it
seems implausible that one number can adequately
describe all aspects of peoples lives and this has
proved technically difficult in other studies (Steward
et al., 1981).
Numerous instruments have been described to
quantify physical or psychological problems in
patients. Most are lengthy and require specially
trained personnel to use them but they may be
valuable in oncological research for detailed study
of particular aspects of patients' lives (Maguire et
al., 1980; McArdle et al., 1981). Fewer attempts
have been made to produce instruments specifically
for use in oncological research or practice
(Priestman & Baum, 1976; Eisenberg &
Goldenburg, 1966; Izsak & Medelie, 1971; Worden
& Weisman, 1977; Padilla et al., 1981; Craig et al.,
1974), and most of these have not been formally
evaluated or widely used. Priestman & Baum (1976)
designed an instrument with 10 (and later 25) items
(Baum et al., 1980) selected on the basis of their
clinical experience and measured by linear analogue
self assessment. Formal evaluation of reliability and
validity was restricted to test-retest scores for an
unweighted sum in 29 patients but the method
performed well in this evaluation and was capable
of distinguishing between groups of patients and22 P.J. SELBY et al.
changes with time. Spitzer et al. (1981) have
described a Quality of Life Index similar to the
Apgar score used in neonatology (5 dimensions
scored 0-2 each and added to an unweighted sum).
This method is quick and easy to use but contains
limited information and results in an unweighted
summary estimation of quality of life which was
evaluated as a sum score.
The measurement instrument described here
seems suitable for general descriptive purposes and
its evaluation suggests that quantitative assessment
of aspects of the quality of life of cancer patients is
possible with relatively simple methods. The
information obtained about some complex areas
such as emotional disorders is limited but further
development and refining of such methods may
provide a valuable additional endpoint in the
investigation of therapy for cancer, particularly
when such therapy may be toxic and the outcome is
often palliation.
Joanne Campbell and Catherine Selby acted as the
Research Officers for this study and their skill and
contribution was fundamental to its success.
We are most grateful to our colleagues in the Ontario
Cancer Institute Health Status Group (Antonio Ciampi,
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The physicians of the Princess Margaret Hospital were
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